Blood transfusion, blood storage and immunomodulation

Area of Science:

• Immunology
• Transfusion Medicine
• Transplantation Immunology

Background:

• Allogeneic blood transfusion is a common allotransplantation procedure without HLA-typing.
• Approximately 50% of recipients develop alloimmunization after receiving unprocessed red cells and platelets.
• Transfusion may induce immunosuppression, potentially enhancing transplant survival but increasing risks of tumor recurrence and infection.

Purpose of the Study:

• To investigate the mechanisms of transfusion-induced alloimmunization and immunosuppression.
• To determine the impact of donor antigen-presenting cells (APCs) viability and function on immune responses.
• To evaluate the effect of refrigerated storage duration on APCs and subsequent immune outcomes.

Main Methods:

• Analysis of APC function, including antigen presentation and costimulatory signaling.
• Assessment of T cell activation (IL-2 secretion, proliferation) in response to transfused cells.
• Correlation of refrigerated storage time with APC apoptosis and immune response.

Main Results:

• Viability and costimulatory capacity of APCs are crucial for alloimmunization.
• APCs lose costimulatory capacity by 14 days of refrigerated storage, potentially causing immunosuppression.
• Storage beyond 3 weeks induces apoptosis in leukocytes, preventing alloantigen recognition and subsequent immune responses.

Conclusions:

• Transfusion of blood stored for over 3 weeks does not lead to alloimmunization.
• Extended refrigerated storage may mitigate transfusion-related immune modulation.
• Understanding storage effects on APCs is key to managing transfusion outcomes.